EUVIMEDEUVIMED entdecken
Kohortenstudie

From a Solitary Blood-Derived Biomarker to Combined Biomarkers of Sarcopenia: Experiences From the Korean Frailty and Aging Cohort Study

Chang Won Won, Miji Kim iD, Hyung Eun Shin

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glae237 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Chang Won Won und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Elderly Frailty Sarcopenia Research Center, College of Medicine, Kyung Hee University, Kyung Hee University Medical Ce…. Hauptthemen laut MEDLINE: Sarcopenia, Frailty, Aging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Republic of Korea, National Institute of Health, Korea Disease Control and Prevention Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia is recognized as a complex and multifactorial disorder that includes nutritional deficiency, inactivity, proinflammatory status, hormonal changes, neurological degeneration, and metabolic disturbances. It’s pathogenesis is not fully understood. Therefore, identifying specific biomarkers of sarcopenia will help us understand its pathophysiology. The most frequently reported blood-derived biomarkers of sarcopenia are growth factors, neuromuscular junctions, endocrine systems, mitochondrial dysfunction, inflammation-mediated and redox processes, muscle protein turnover, blood metabolomics, and behavior-mediated biomarkers. Here, we address the implications of sarcopenia biomarkers based on our research experience with Korean Frailty and Aging Cohort Study cohort data. It includes free testosterone, myostatin, fibroblast growth factor 21 (FGF-21), growth differentiation factor 15 (GDF-15), procollagen type III N-terminal peptide (P3NP), creatinine-based biomarkers, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), brain-derived neurotrophic factor (BDNF), metabolites (proline, alanine, tryptophan), and multi-biomarker risk score. We attempted to explain the paradoxical findings of myostatin and FGF-21 levels in relation to sarcopenia. GDF-15 levels were associated with sarcopenia prevalence but not its incidence. Plasma P3NP and BDNF levels may be biomarkers of muscle quality rather than quantity. Lower erythrocyte eicosapentaenoic acid (EPA) and docosahexaenoic acid levels were associated with slow gait speed, and erythrocyte EPA levels were associated with low handgrip strength. We developed a multi-biomarker risk score for sarcopenia and found that its accuracy in diagnosing sarcopenia was higher than that of any single biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaFrailtyAgingHumansBiomarkersRepublic of KoreaMaleAgedFemaleGrowth Differentiation Factor 15Cohort StudiesFibroblast Growth FactorsAged, 80 and overMyostatinMiddle Aged

Stichwörter der Autor:innen

BiomarkerOlder adultsSarcopenia

Substanzen

BiomarkersGrowth Differentiation Factor 15GDF15 protein, humanFibroblast Growth FactorsMyostatinfibroblast growth factor 21

Autor:innen und Institutionen

  • Department of Family Medicine, Elderly Frailty Sarcopenia Research Center, College of Medicine, Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea.
  • Department of Health Sciences and Technology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Orthopaedics, Emory Musculoskeletal Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Miji Kim

Förderung

  • Ministry of Health and Welfare, Republic of Korea
  • National Institute of Health, Korea Disease Control and Prevention Agency

Zitieren

APA

Won, C. W., Kim, M., & Shin, H. E. (2025). From a Solitary Blood-Derived Biomarker to Combined Biomarkers of Sarcopenia: Experiences From the Korean Frailty and Aging Cohort Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glae237

Vancouver

Won CW, Kim M, Shin HE. From a Solitary Blood-Derived Biomarker to Combined Biomarkers of Sarcopenia: Experiences From the Korean Frailty and Aging Cohort Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glae237

BibTeX
@article{Won2025,
  author = {Won, Chang Won and Kim, Miji and Shin, Hyung Eun},
  title = {From a Solitary Blood-Derived Biomarker to Combined Biomarkers of Sarcopenia: Experiences From the Korean Frailty and Aging Cohort Study},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glae237}
}
Kostenlos starten →